157 related articles for article (PubMed ID: 35918245)
1. Endometrial thickness assessed by transvaginal ultrasound in transmasculine people taking testosterone compared with cisgender women.
Asseler JD; Caanen MR; Verhoeven MO; Huirne JAF; Goddijn M; van Dulmen-den Broeder E; Overbeek A; Lambalk CB; van Mello NM
Reprod Biomed Online; 2022 Nov; 45(5):1033-1038. PubMed ID: 35918245
[TBL] [Abstract][Full Text] [Related]
2. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gomez-Lobo V; Gray M
Am J Obstet Gynecol; 2019 Mar; 220(3):257.e1-257.e7. PubMed ID: 30579875
[TBL] [Abstract][Full Text] [Related]
3. HIV prevalence among transmasculine individuals at a New York City Community Health Centre: a cross-sectional study.
Radix AE; Larson EL; Harris AB; Chiasson MA
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25981. PubMed ID: 36225145
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Exogenous Testosterone on Breast Cancer Risk in Transmasculine Individuals.
Gurrala RR; Kumar T; Yoo A; Mundinger GS; Womac DJ; Lau FH
Ann Plast Surg; 2023 Jan; 90(1):96-105. PubMed ID: 36534108
[TBL] [Abstract][Full Text] [Related]
5. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy.
Hawkins M; Deutsch MB; Obedin-Maliver J; Stark B; Grubman J; Jacoby A; Jacoby VL
Fertil Steril; 2021 May; 115(5):1312-1317. PubMed ID: 33583596
[TBL] [Abstract][Full Text] [Related]
6. Contraception across the transmasculine spectrum.
Krempasky C; Harris M; Abern L; Grimstad F
Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Mortality Among Transgender and Gender Diverse Adults in England.
Jackson SS; Brown J; Pfeiffer RM; Shrewsbury D; O'Callaghan S; Berner AM; Gadalla SM; Shiels MS
JAMA Netw Open; 2023 Jan; 6(1):e2253687. PubMed ID: 36716027
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data.
Brown J; Pfeiffer RM; Shrewsbury D; O'Callaghan S; Berner AM; Gadalla SM; Shiels MS; Jackson SS
Br J Gen Pract; 2023 Jul; 73(732):e486-e492. PubMed ID: 37365010
[TBL] [Abstract][Full Text] [Related]
10. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gray M; Gomez Lobo V
J Sex Med; 2020 Sep; 17(9):1807-1818. PubMed ID: 32703706
[TBL] [Abstract][Full Text] [Related]
12. Chest Reconstruction and Chest Dysphoria in Transmasculine Minors and Young Adults: Comparisons of Nonsurgical and Postsurgical Cohorts.
Olson-Kennedy J; Warus J; Okonta V; Belzer M; Clark LF
JAMA Pediatr; 2018 May; 172(5):431-436. PubMed ID: 29507933
[TBL] [Abstract][Full Text] [Related]
13. Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals.
Baker GM; Bret-Mounet VC; Xu J; Fein-Zachary VJ; Tobias AM; Bartlett RA; Clohessy JG; Vlachos IS; Massicott ES; Wulf GM; Schnitt SJ; Heng YJ
Mod Pathol; 2023 Jun; 36(6):100121. PubMed ID: 36889065
[TBL] [Abstract][Full Text] [Related]
14. Transmasculine people's vocal situations: a critical review of gender-related discourses and empirical data.
Azul D
Int J Lang Commun Disord; 2015; 50(1):31-47. PubMed ID: 25180865
[TBL] [Abstract][Full Text] [Related]
15. Bacterial vaginosis testing gaps for transmasculine patients may exacerbate health disparities.
Thompson HM; Rusie LK; Schneider JA; Mehta SD
Front Reprod Health; 2024; 6():1344111. PubMed ID: 38449898
[TBL] [Abstract][Full Text] [Related]
16. Expected vs. perceived effects of gender-affirming hormone therapy among transmasculine adolescents.
Taillefer V; Kelley J; Marsolais S; Chiniara L; Chadi N
J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1072-1078. PubMed ID: 37747085
[TBL] [Abstract][Full Text] [Related]
17. Management of testosterone around ovarian stimulation in transmasculine patients: challenging common practices to meet patient needs-2 case reports.
Moravek MB; Dixon M; Pena SM; Obedin-Maliver J
Hum Reprod; 2023 Mar; 38(3):482-488. PubMed ID: 36644915
[TBL] [Abstract][Full Text] [Related]
18. 2D/3D ultrasonography for endometrial evaluation in a cohort of 118 postmenopausal women with abnormal uterine bleedings.
Stachowiak G; Zając A; Pertynska-Marczewska M; Stetkiewicz T
Ginekol Pol; 2016; 87(12):787-792. PubMed ID: 28098928
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
20. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
